Luigi Mangione Intends to Plead Guilty in Federal Case Over UnitedHealthcare CEO Killing

On Friday, lawyers representing Luigi Mangione informed a Manhattan federal court that the 28-year-old intends to plead guilty to federal stalking charges connected to the December 2024 killing of UnitedHealthcare CEO Brian Thompson. Specifically, defense attorneys made the revelation during a hearing before U.S. District Judge Margaret M. Garnett. In addition, if finalized, the plea resolves the federal prosecution and averts a federal trial that was tentatively slated for January. However, legal experts note that the unexpected turn could throw his upcoming New York state murder trial into procedural disarray.

Double Jeopardy Protections and State Murder Trial Impact

In fact, the decision to enter a guilty plea in federal court directly targets the parallel state prosecution brought by Manhattan District Attorney Alvin Bragg. Previously, Judge Gregory Carro scheduled jury selection in the state murder trial to begin on September 8, 2026. Consequently, a finalized federal guilty plea allows Mangione’s defense team to invoke New York’s broad double jeopardy statutes. Under state law, prosecution for offenses arising from the same criminal act is barred if a defendant has already pleaded guilty to a federal offense covering the same conduct.

Case Trajectory & Legal Sequence

(Progression of federal and state court proceedings)

↓

December 2024 Shooting & Arrest

(Brian Thompson killed in Manhattan; Mangione apprehended in Pennsylvania days later)

↓

Federal Murder Charges Dismissed (Jan 2026)

(Judge Garnett tosses federal murder counts, leaving stalking charges carrying life sentences)

↓

State Trial Scheduled (Sept 2026)

(State court orders anonymous jury selection for September 8 murder trial)

↓

Federal Guilty Plea Hearing (Aug 2026)

(Defense confirms intent to plead guilty to federal stalking charges)

Furthermore, Manhattan state prosecutors have vowed to resist any effort to dismiss the state murder indictment, arguing that state homicide laws address distinct legal interests from federal stalking.

“It’s the same trial twice. One plus one is two. Double jeopardy by any commonsense definition.”

— Luigi Mangione, statement to the court during a February 2026 pretrial hearing

Background of the High-Profile Investigation

Indeed, the charges stem from the December 4, 2024 ambush outside the New York Hilton Midtown, where Thompson was gunned down as he walked to UnitedHealth Group’s annual investor conference. Following a five-day nationwide search, police arrested Mangione at a fast-food restaurant in Altoona, Pennsylvania. During the arrest, authorities recovered a 3D-printed handgun and a notebook expressing deep hostility toward the U.S. for-profit healthcare system.

Ultimately, whether the plea agreement stands depends on Mangione formally affirming his guilty plea in open court before Judge Garnett. Meanwhile, attorneys on both sides prepare for an intense appellate fight over whether the state murder trial can legally proceed.

Case Parameter / Metric	Federal Prosecution Status	New York State Prosecution Status
Primary Charges	Stalking resulting in death (2 counts).	Second-degree murder, weapons, forgery.
Maximum Penalty	Life in prison without parole.	25 years to life in prison.
Current Status	Guilty plea announced August 14, 2026.	Jury selection set for Sept 8, 2026.
Key Legal Strategy	Resolves federal case to avert trial.	Defense seeking double jeopardy dismissal.

Sources

• Associated Press – Luigi Mangione’s lawyers say he is pleading guilty to killing UnitedHealthcare CEO
• PBS NewsHour – Luigi Mangione to appear in court for expected guilty plea in killing of UnitedHealthcare CEO
• The Guardian – Luigi Mangione hearing fuels speculation of a guilty plea in federal case
• SBS News – Luigi Mangione says he will plead guilty in federal case